Study Finds Insulin-Free Glucose Pathway in Muscle

University of Cincinnati researchers identified a muscle glucose uptake route that works without insulin, which could inform future diabetes treatments.

Updated on Nov. 20, 2026 in Diseases

Bold flat-color editorial illustration of a row of amber-filled glass vials beside a stainless-steel instrument, evoking laboratory research into muscle glucose uptake.
University of Cincinnati researchers identified an insulin-independent glucose pathway in skeletal muscle, called mSGLT, that could inform future diabetes and insulin resistance treatments. AI Illustration. Upload story photo >

Live Poll

Do you think new diabetes drugs will meaningfully improve blood sugar control?

Researchers at the University of Cincinnati identified an insulin-independent pathway, called mSGLT, that allows skeletal muscle to take up glucose. The findings were published in the journal Communications Biology.

Why it matters

Current glucose-lowering approaches largely depend on insulin signaling, so a pathway that operates without it may offer a new drug target for diabetes and insulin resistance. The work could help explain how muscles keep absorbing glucose when insulin levels are low.

The study used isolated animal muscles stimulated electrically to mimic exercise, measuring uptake with glucose derivatives that SGLT-type transporters carry but GLUT4 does not. Whether these animal-model results translate to human muscle and blood sugar control remains unconfirmed.

The players

University of Cincinnati College of Medicine

A public medical school in Cincinnati, Ohio, that conducts biomedical research on metabolic diseases including diabetes.

Icahn School of Medicine at Mount Sinai

A medical school in New York City affiliated with the Mount Sinai Health System, known for research across biomedical science.

The details

The team, led by Judith A. Heiny, PhD, in the University of Cincinnati College of Medicine, tested muscles under insulin-free conditions to examine glucose transport. Collaborators at the Icahn School of Medicine at Mount Sinai contributed a measurement technique based on inductively coupled plasma mass spectroscopy.

Timeline

  1. Study findings were reported in November 2026.

Health Landscape

The mSGLT pathway shares properties with SGLT2, the kidney glucose transporter targeted by drugs such as Jardiance, extending that drug-target logic into skeletal muscle. If confirmed, it would shift attention beyond the insulin-dependent GLUT4 transporter that has dominated muscle glucose research.

No treatment or product changes for patients follow from this study yet. Any future drug would still need to be developed and tested in humans before affecting daily diabetes management.

The takeaway

Muscles can absorb glucose through a route that does not depend on insulin, which could matter for people with insulin resistance. Readers managing blood sugar should keep following their clinician's guidance while further research clarifies what this pathway means for treatment.

Further reading

For more on related research, explore Diabetes coverage in Cincinnati.

Live Poll

Do you think new diabetes drugs will meaningfully improve blood sugar control?